|
Michael J. Pellini, M.D. recently joined Clarient, Inc. as Chief Operating Officer, while he continues to serve as a senior member of Safeguard Scientifics, Inc.’s Life Science team, and a member of Clarient's Board of Directors. Mike draws upon years of experience in life sciences and laboratory executive management to support Clarient’s operations as the company continues its rapid growth and market expansion.
As a member of Safeguard’s Life Sciences team, Mike leverages his business and medical expertise to explore new market opportunities, evaluate growth potential of prospects and provide support to Safeguard and its partner companies. Prior to joining Safeguard, Mike was Chief Operating Officer at Lakewood Pathology Associates, Inc., a national anatomical pathology company that provides comprehensive molecular and pathology services tailored toward the outpatient needs of surgical sub-specialists. Prior to that, Mike was an Entrepreneur in Residence at BioAdvance, where he was responsible for reviewing and evaluating seed stage investment proposals. From 1999 to 2004, Mike served as President and Chief Executive Officer of Genomics Collaborative, Inc., a Boston-based biotech firm that was acquired by SeraCare Life Sciences, Inc. in 2004.
Mike is a native of the greater Philadelphia region. He trained as a primary care physician in the Thomas Jefferson University Health System. Before attending medical school, he worked in the investment banking industry in both Philadelphia and Sydney, Australia.
Education
BA, Boston College
MBA, Drexel University
MD, Jefferson Medical College of Thomas Jefferson University
Previous Experience
Lakewood Pathology Associates, Inc. Executive Vice President / Chief Operating Officer
BioAdvance Entrepreneur in Residence
Genomics Collaborative, Inc. President and CEO
Current Boards
Clarient, Inc.
Cellumen, Inc.
Cira Discovery, Inc.
Coriell Institute of Medical Research Executive Committee of the Board of Trustees
Jefferson Medical College Alumni Association Executive Committee
Boston College Technology Council
Journal of Biotechnology Healthcare Editorial Board
| 